Johns Hopkins Medicine: Researchers Id Novel Treatment Pathway For Deadly Pancreatic Cancers
April 25, 2023
April 25, 2023
BALTIMORE, Maryland, April 25 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.
In laboratory studies with human pancreatic cancer cell lines and genetically engineered mouse models of pancreatic cancer, the investigators discovered that the High Mobility Group A . . .
Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.
In laboratory studies with human pancreatic cancer cell lines and genetically engineered mouse models of pancreatic cancer, the investigators discovered that the High Mobility Group A . . .